N-(2-chloro-6-methoxyphenyl)-2,2-dimethylpropionamide | 934537-35-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(2-chloro-6-methoxyphenyl)-2,2-dimethylpropionamide
• 英文别名: N-(2-chloro-6-methoxyphenyl)-2,2-dimethylpropanamide
• CAS: 934537-35-6
• 化学式: C₁₂H₁₆ClNO₂
• 分子量: 241.718
• InChiKey: VRQCQOASVHGGSY-UHFFFAOYSA-N

物化性质

• 沸点：
  352.6±27.0 °C(Predicted)
• 密度：
  1.161±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-(2-chloro-6-methoxyphenyl)-2,2-dimethylpropionamide 在 氢溴酸 作用下， 以92%的产率得到2-氨基-3-氯苯酚
  参考文献：
  名称：

  Difluoromethylbenzoxazole Pyrimidine Thioether Derivatives: A Novel Class of Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors

  摘要：

  This paper reports the synthesis and antiviral properties of new difluoromethylbenzoxazole (DFMB) pyrimidine thioether derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors. By use of a combination of structural biology study and traditional medicinal chemistry, several members of this novel class were synthesized using a single electron transfer chain process (radical nucleophilic substitution, Si) and were found to be potent against wild-type HIV-1 reverse transcriptase, with low cytotoxicity but with moderate activity against drug-resistant strains. The most promising compound 2,4 showed a significant EC50 value close to 6.4 nM against HIV-1 IIIB, a moderate EC50 value close to 54 mu M against an NNRTI resistant double mutant (K103N + Y181C), but an excellent selectivity index >15477 (CC50 > 100 mu M).

  DOI：

  10.1021/jm200766b
• 作为产物：
  描述：

  N-(新戊酰基)邻茴香胺 在 正丁基锂 、 六氯乙烷 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 3.5h， 以770.4 mg的产率得到N-(2-chloro-6-methoxyphenyl)-2,2-dimethylpropionamide
  参考文献：
  名称：

  Difluoromethylbenzoxazole Pyrimidine Thioether Derivatives: A Novel Class of Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors

  摘要：

  This paper reports the synthesis and antiviral properties of new difluoromethylbenzoxazole (DFMB) pyrimidine thioether derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors. By use of a combination of structural biology study and traditional medicinal chemistry, several members of this novel class were synthesized using a single electron transfer chain process (radical nucleophilic substitution, Si) and were found to be potent against wild-type HIV-1 reverse transcriptase, with low cytotoxicity but with moderate activity against drug-resistant strains. The most promising compound 2,4 showed a significant EC50 value close to 6.4 nM against HIV-1 IIIB, a moderate EC50 value close to 54 mu M against an NNRTI resistant double mutant (K103N + Y181C), but an excellent selectivity index >15477 (CC50 > 100 mu M).

  DOI：

  10.1021/jm200766b

文献信息

• Benzoxazoles Useful in the Treatment of Inflammation
  申请人：Pelcman Benjamin

  公开号：US20090258917A1

  公开（公告）日：2009-10-15

  There is provided the use of a compound of formula I, wherein Y, W 1 to W 4 , Z 1 to Z 4 and R have meanings given in the description, and pharmaceutically-acceptable salts thereof, for the manufacture of a medicament for the treatment of a disease in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation.

  本发明提供了使用式I的化合物及其药学上可接受的盐的制备药物，用于治疗需要或希望抑制MAPEG家族成员活性的疾病，尤其是治疗炎症。其中，Y，W1至W4，Z1至Z4和R的含义详见说明书。
• WO2007/42816
  申请人：——

  公开号：——

  公开（公告）日：——
• Difluoromethylbenzoxazole Pyrimidine Thioether Derivatives: A Novel Class of Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors
  作者：Jérémie Boyer、Eric Arnoult、Maurice Médebielle、Jérôme Guillemont、Johan Unge、Dirk Jochmans

  DOI：10.1021/jm200766b

  日期：2011.12.8

  This paper reports the synthesis and antiviral properties of new difluoromethylbenzoxazole (DFMB) pyrimidine thioether derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors. By use of a combination of structural biology study and traditional medicinal chemistry, several members of this novel class were synthesized using a single electron transfer chain process (radical nucleophilic substitution, Si) and were found to be potent against wild-type HIV-1 reverse transcriptase, with low cytotoxicity but with moderate activity against drug-resistant strains. The most promising compound 2,4 showed a significant EC50 value close to 6.4 nM against HIV-1 IIIB, a moderate EC50 value close to 54 mu M against an NNRTI resistant double mutant (K103N + Y181C), but an excellent selectivity index >15477 (CC50 > 100 mu M).